Viewing Study NCT00358566


Ignite Creation Date: 2025-12-24 @ 4:23 PM
Ignite Modification Date: 2026-02-03 @ 12:42 AM
Study NCT ID: NCT00358566
Status: TERMINATED
Last Update Posted: 2008-05-19
First Post: 2006-07-14
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: GV1001 and Gemcitabine in Sequential Combination to Gemcitabine Monotherapy in Pancreatic Cancer
Sponsor: Pharmexa A/S
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Unresectable Pancreatic Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Advanced View
None Unresesctable View
None Adenocarcinoma View
None Pancreatic cancer View